Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — |
| Research & development | $41.1M | $50.5M | $47.3M | $37.7M | $29.4M | $12.4M |
| Operating expenses | $66.8M | $81.5M | $76.2M | $63.6M | $50.5M | $15.7M |
| Operating income | −$66.8M | −$81.5M | −$76.2M | −$63.6M | — | −$576,035 |
| EBITDA | −$60.4M | −$75.0M | −$70.4M | −$60.2M | — | $133,965 |
| Net income | −$59.0M | −$70.8M | −$63.7M | −$57.9M | −$50.3M | −$15.6M |
| Basic EPSper basic share | -$0.47 | -$0.56 | -$0.51 | -$0.46 | -$0.60 | -$0.54 |
| Diluted EPSper diluted share | -$0.47 | -$0.56 | -$0.51 | -$0.46 | -$0.60 | -$0.54 |
Reported shareholders
| Holder | % owned |
|---|---|
Mallick Parag | ≈16.11%20.49M shares |
Patel Sujal M | ≈13.72%17.46M shares |
AH Bio Fund II, L.P. / HOROWITZ BENJAMIN A / AH Equity Partners LSV II, L.L.C. / Andreessen Horowitz LSV Fund II, L.P. / Andreessen Marc L / AH Equity Partners Bio II, L.L.C. | ≈9.95%12.65M shares |
PERCEPTIVE ADVISORS LLC | 9.14%11.63M shares |
a16z Capital Management, L.L.C. | 7.12%9.06M shares |
Cercano Management LLC | 5.64%7.17M shares |
BlackRock, Inc. | 2.11%2.69M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 2.00%2.55M shares |
Comprehensive Financial Management LLC | 1.74%2.21M shares |
CITADEL ADVISORS LLC | 1.49%1.9M shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.99%1.27M shares |
ACADIAN ASSET MANAGEMENT LLC | 0.83%1.06M shares |
Clearstead Advisors, LLC | 0.70%892.79K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.70%890.95K shares |
SENTINEL TRUST CO LBA | 0.59%750K shares |
BARCLAYS PLC | 0.57%725.32K shares |
RENAISSANCE TECHNOLOGIES LLC | 0.54%690.51K shares |
JPMORGAN CHASE & CO | 0.48%614.18K shares |
STATE STREET CORP | 0.44%559.51K shares |
DIMENSIONAL FUND ADVISORS LP | 0.37%475.84K shares |
Percentages use 127.22M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 2, 2026Form 4 | AH Bio Fund II, L.P. +5TenPercentOwner | SellCommon Stock · indirect | 384.0K | $2.35 | $902.5K | 971.9K |
| Jun 2, 2026Form 4 | AH Bio Fund II, L.P. +5TenPercentOwner | SellCommon Stock · indirect | 4.62M | $2.35 | $10.85M | 11.68M |
| Mar 4, 2026Form 4 | Patel Sujal MCEO, President, and Secretary | BuyCommon Stock | 25.0K | $2.61 | $65.3K | 10.37M |
| Nov 6, 2025Form 4 | Suzuki KentaroChief Marketing Officer | BuyCommon Stock | 4.0K | $1.49 | $6.0K | 4.0K |
| Sep 8, 2025Form 4 | Patel Sujal MCEO, President, and Secretary | BuyCommon Stock | 83.5K | $0.68 | $56.8K | 10.34M |